Impact of CRTC1/3–MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma
✍ Scribed by Yoshihide Okumura; Satoru Miyabe; Takahisa Nakayama; Yukio Fujiyoshi; Hideo Hattori; Kazuo Shimozato; Hiroshi Inagaki
- Book ID
- 110092824
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 137 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0309-0167
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mucoepidermoid carcinomas (MECs) of the salivary and bronchial glands are characterized by a recurrent t(11;19)(q21;p13) translocation resulting in a __MECT1__–__MAML2__ fusion in which the CREB‐binding domain of the CREB coactivator MECT1 (also known as CRTC1, TORC1 or WAMTP1) is fused
## Abstract Recently, the concept of cancer stem cells and their expression of embryonic stem cell markers has gained considerable experimental support. In this study, we examined the expression of one such marker, the __high‐mobility group AT‐hook 2 gene (HMGA2)__ mRNA, in 53 formalin‐fixed, paraf
## Abstract We analyzed 55 primary salivary gland tumors including 22 mucoepidermoid carcinomas (MECs) to determine the association of __MECT1/TORC1/CRTC1‐MAML2__ fusion transcript to tumor types, level of MEC differentiation and clinicopathologic parameters. Our primary salivary gland tumors were